SECTOR GAMMA AS - Q2 2022 holdings

$447 Million is the total value of SECTOR GAMMA AS's 37 reported holdings in Q2 2022. The portfolio turnover from Q1 2022 to Q2 2022 was 22.5% .

 Value Shares↓ Weighting
GILD BuyGILEAD SCIENCES INC$52,132,000
+28.7%
843,427
+23.8%
11.66%
+32.5%
MRK SellMERCK & CO INC$37,775,000
-7.8%
414,338
-17.0%
8.45%
-5.0%
INCY BuyINCYTE CORP$34,903,000
-0.6%
459,429
+3.9%
7.81%
+2.4%
MDT BuyMEDTRONIC PLC$26,074,000
+14.1%
290,521
+41.0%
5.83%
+17.5%
BMY SellBRISTOL-MYERS SQUIBB CO$24,001,000
-1.5%
311,696
-6.6%
5.37%
+1.5%
CAH BuyCARDINAL HEALTH INC$20,176,000
-5.7%
385,988
+2.3%
4.51%
-2.9%
BSX BuyBOSTON SCIENTIFIC CORP$19,855,000
+13.4%
532,735
+34.8%
4.44%
+16.7%
BIIB BuyBIOGEN INC$18,864,000
+9.3%
92,497
+12.9%
4.22%
+12.6%
CI BuyCIGNA CORP NEW$17,467,000
+24.9%
66,283
+13.6%
3.91%
+28.6%
ANTM BuyELEVANCE HEALTH INC$16,552,000
+16.1%
34,300
+18.2%
3.70%
+19.6%
BRKR SellBRUKER CORP$15,755,000
-2.8%
251,042
-0.4%
3.52%
+0.1%
CVS SellCVS HEALTH CORP$15,577,000
-22.6%
168,111
-15.5%
3.48%
-20.3%
CNC SellCENTENE CORP DEL$15,382,000
-6.1%
181,799
-6.6%
3.44%
-3.3%
ZBH BuyZIMMER BIOMET HOLDINGS INC$14,262,000
+72.1%
135,749
+109.5%
3.19%
+77.2%
NUVA SellNUVASIVE INC$12,167,000
-19.3%
247,502
-7.0%
2.72%
-17.0%
OGN BuyORGANON & CO$12,018,000
+1.3%
356,089
+4.8%
2.69%
+4.3%
QGEN SellQIAGEN NV$9,522,000
-11.4%
201,729
-8.0%
2.13%
-8.7%
VRTX BuyVERTEX PHARMACEUTICALS INC$9,433,000
+46.0%
33,474
+35.2%
2.11%
+50.4%
SGEN NewSEAGEN INC$8,988,00050,795
+100.0%
2.01%
BMRN BuyBIOMARIN PHARMACEUTICAL INC$8,723,000
+41.9%
105,259
+32.0%
1.95%
+46.1%
ALNY SellALNYLAM PHARMACEUTICALS INC$6,249,000
-35.4%
42,844
-27.7%
1.40%
-33.5%
IONS SellIONIS PHARMACEUTICALS INC$6,125,000
-12.2%
165,439
-12.2%
1.37%
-9.7%
BIO SellBIO RAD LABS INCcl a$5,834,000
-19.0%
11,785
-7.8%
1.30%
-16.6%
ABT NewABBOTT LABS$5,346,00049,205
+100.0%
1.20%
PFE SellPFIZER INC$5,243,000
-21.9%
100,000
-22.9%
1.17%
-19.7%
ITCI  INTRA-CELLULAR THERAPIES INC$4,615,000
-6.7%
80,8430.0%1.03%
-3.9%
SAGE  SAGE THERAPEUTICS INC$3,827,000
-2.4%
118,4760.0%0.86%
+0.5%
PTCT BuyPTC THERAPEUTICS INC$3,400,000
+14.1%
84,864
+6.3%
0.76%
+17.4%
NVAX BuyNOVAVAX INC$2,845,000
+0.8%
55,324
+44.4%
0.64%
+3.9%
VIR BuyVIR BIOTECHNOLOGY INC$2,807,000
+36.1%
110,223
+37.4%
0.63%
+40.2%
RARE  ULTRAGENYX PHARMACEUTICAL IN$2,758,000
-17.8%
46,2210.0%0.62%
-15.4%
UHS SellUNIVERSAL HLTH SVCS INCcl b$2,727,000
-60.4%
27,077
-43.0%
0.61%
-59.2%
RIGL  RIGEL PHARMACEUTICALS INC$1,657,000
-62.2%
1,466,6780.0%0.37%
-61.1%
QTRX  QUANTERIX CORP$1,436,000
-44.5%
88,6700.0%0.32%
-42.9%
 SOMALOGIC INC$1,362,000
-43.6%
301,2240.0%0.30%
-41.9%
ATRA  ATARA BIOTHERAPEUTICS INC$964,000
-16.1%
123,7130.0%0.22%
-13.6%
NewEMBECTA CORP$133,0005,246
+100.0%
0.03%
MRTX ExitMIRATI THERAPEUTICS INC$0-11,875
-100.0%
-0.21%
XRAY ExitDENTSPLY SIRONA INC$0-55,516
-100.0%
-0.59%
PDCO ExitPATTERSON COS INC$0-129,757
-100.0%
-0.91%
BDX ExitBECTON DICKINSON & CO$0-26,233
-100.0%
-1.52%
AZN ExitASTRAZENECA PLCsponsored adr$0-124,000
-100.0%
-1.79%
ELAN ExitELANCO ANIMAL HEALTH INC$0-364,691
-100.0%
-2.07%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2022-08-05
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
BOSTON SCIENTIFIC CORP40Q1 20239.9%
BIO RAD LABS INC40Q1 20234.7%
BRISTOL-MYERS SQUIBB CO38Q3 202311.9%
BAXTER INTL INC34Q3 202312.7%
CARDINAL HEALTH INC34Q3 20238.1%
PERKINELMER INC33Q2 20216.3%
BIOGEN INC30Q3 20237.6%
ELEVANCE HEALTH INC30Q3 20235.6%
GILEAD SCIENCES INC29Q3 202314.0%
TENET HEALTHCARE CORP28Q3 20234.3%

View SECTOR GAMMA AS's complete holdings history.

Latest filings
TypeFiled
13F-HR2024-02-05
13F-HR2023-11-06
13F-HR2023-08-09
13F-HR2023-05-12
13F-HR/A2023-02-08
13F-HR2023-02-07
13F-HR2022-11-09
13F-HR2022-08-05
13F-HR2022-05-06
13F-HR2022-02-08

View SECTOR GAMMA AS's complete filings history.

Compare quarters

Export SECTOR GAMMA AS's holdings